Midsummer updates

We took a temporary hiatus from blogging starting in March right after my Rare Disease Day post. The reason: fundraising. Raising money is personally all-consuming for the CEO, as I’ll attest in an upcoming post. It’s also a persistent distraction for the...
World Rare Disease Day 2017

World Rare Disease Day 2017

This post is dedicated to World Rare Disease Day (WRDD) 2017. It was at the WRRD four years earlier when the value proposition for Perlara crystalized in my mind. I went to NIH that frosty last day of February in order to meet with patient advocates and ask them one...
2016 in review

2016 in review

“Last Month in Tweets” was on again, off again in 2016. Apologies, we’ll be more consistent with monthly updates across the board in 2017. For now, let’s relive the best moments of 2016 at Perlara! Although I wasn’t able to announce it...
Perlara’s first preprint

Perlara’s first preprint

Two weeks ago we posted Perlara’s first preprint to bioRxiv, along with all the raw data on GitHub: Predicting the phenotype of Mendelian disease missense mutations using amino acid conservation and … https://t.co/PWBuYakkMI #bioRxiv — bioRxiv...
Introducing Perlara

Introducing Perlara

Last month at the 5th annual Global Genes Patient Summit, we announced our rebrand from Perlstein Lab PBC to Perlara PBC. Together with our partners at Valley Design Group, we created a new logo/mark that embodies the excitement and hope of scientific discovery. To go...
Translate »